ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

252
Analysis
Health Care • India
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company that researches, develops, manufactures, and markets a wide array of pharmaceutical products and services. The company produces over 190 medications, 60 active pharmaceutical ingredients, diagnostic kits, critical care, and biotechnology products. It operates globally across multiple regions, offering generic drugs, active pharmaceutical ingredients (APIs), differentiated formulations, biosimilars, and proprietary products. The company was founded in 1984 and is headquartered in Hyderabad, Telangana, India.
more
•29 Jan 2020 07:51

EM Pullback Opportunity

Supporting our global bull market thesis, uptrends remain intact for the major global indexes (MSCI ACWI, ACWI ex-US, EAFE, and EM). At this point,...

Logo
620 Views
Share
•18 Jun 2019 14:39

Shikha Sharma Rewarded with Prominent Directorships for Mismanagement at Axis Bank

On June 14, 2019, Tech Mahindra (TECHM IN)  joined the ranks of Tata Global Beverages, Ambuja Cements (ACEM IN)  and Dr. Reddy'S Laboratories (DRRD...

Logo
760 Views
Share
bullish•Quantitative Analysis
•01 Jun 2026 10:01

NIFTY Index Earning Revision (May): Bharti Airtel, Oil & Natural Gas, Grasim Industries

We analyzed NIFTY's consensus for May 2026 and highlighted changes of EPS in Bharti Airtel, Oil & Natural Gas, Grasim Industries, State Bank of...

Logo
139 Views
Share
•22 Dec 2018 06:01

EM Relative Strength Is Bottoming: Overweight

Relative strength for MSCI EM is bottoming vs. MSCI EAFE despite continued global equity market weakness.  Although the MSCI EM's price index...

Logo
1.3k Views
Share
bearish•MSCI ACWI Index
•20 Dec 2018 22:08

Global Markets Deteriorating...Except EM

With U.S. markets stumbling, the MSCI ACWI index is breaking down to new lows: defensive Sectors remain attractive. Relative to MSCI ACWI however,...

Logo
1.1k Views
Share
x